Akari Therapeutics Plc Quarterly Preferred Stock, Par or Stated Value Per Share in USD/shares from Q4 2022 to Q2 2024

Taxonomy & unit
us-gaap: USD/shares
Description
Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.
Summary
Akari Therapeutics Plc quarterly Preferred Stock, Par or Stated Value Per Share history and growth rate from Q4 2022 to Q2 2024.
  • Akari Therapeutics Plc Preferred Stock, Par or Stated Value Per Share for the quarter ending June 30, 2024 was 0 USD/shares.
Preferred Stock, Par or Stated Value Per Share, Quarterly (USD/shares)
Preferred Stock, Par or Stated Value Per Share, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $0 Jun 30, 2024 8-K 2024-09-06
Q4 2023 $0 $0 0% Dec 31, 2023 8-K 2024-09-06
Q4 2022 $0 Dec 31, 2022 8-K 2024-09-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.